China688617.CG▲
Medical device sector reaches inflection point, STAR Healthcare ETF ChinaAMC holds over 34% in devices
A research note from China Securities points out that the medical device sector has reached an inflection point. In the first quarter of 2026, the pharmaceutical industry's total revenue grew 2.16% year on year, while core net profit attributable to shareholders rose 2.69%, showing an improving trend. The STAR Biomedical Index tracked by the STAR Healthcare ETF ChinaAMC has a medical device weighting exceeding 34%, with the top ten holdings including device leaders such as United Imaging Healthcare, Yirui Technology, and Huitai Medical. China Securities believes that as the impact of policies like volume-based procurement gradually fades, the device sector is poised for a dual recovery in valuations and earnings, with key opportunities coming from earnings recovery, overseas expansion, surgical robots, and brain-computer interfaces. As of 10 July 2026, the latest circulating size of the STAR Healthcare ETF ChinaAMC reached 249 million yuan, a new high over the past year.
688271.CG · Demand · Positive Medical device sector at inflection point with dual recovery in valuations and earnings, benefiting device leaders like United Imaging.
688301.CG · Demand · Positive Medical device sector at inflection point with dual recovery in valuations and earnings, benefiting device leaders like iRay Technology.
688617.CG · Demand · Positive Medical device sector at inflection point with dual recovery in valuations and earnings, benefiting device leaders like APT Medical.